Article 03 · Metabolism · 7 minutes

Insulin resistance in PCOS, and what actually moves it

Most women with PCOS have it, few can see it on a lab form, and the things that move it are not the ones the internet sells.

Anna LaurentCoach, sports nutrition · Precision Nutrition L1, CSCS
Reviewed8 November 2026, Anna Szabó
Based onThe 2023 international guideline
In short
  • Across 28 clamp studies, insulin sensitivity was about 27 percent lower in women with PCOS than in controls, independent of BMI; a higher BMI took it down a further 15 percent (3).
  • Women with PCOS have about three times the odds of impaired glucose tolerance and type 2 diabetes (4), which is why the guideline asks for a glucose test at diagnosis and every one to three years (1).
  • The guideline does not recommend fasting insulin or HOMA-IR in routine care; it measures glucose handling instead (1).
  • What moves it: muscle work, a plate built on protein and fiber, sleep, and, where a doctor decides, metformin. No single diet or exercise type is superior (1).

What insulin resistance is

Insulin is the hormone that moves glucose out of the blood and into muscle, liver and fat cells after a meal. Insulin resistance means those cells answer the signal less readily, so the pancreas sends more insulin to get the same job done. For years the glucose on a lab form can look normal while insulin runs high in the background; glucose only rises once the pancreas can no longer keep up (2).

In PCOS this is not a side issue. The guideline calls insulin resistance a pathophysiological factor of the condition itself (1), and the mechanism is partly specific to PCOS: a signaling defect in the insulin receptor pathway of muscle and fat cells that is present in lean women too (2). That matters, because it means the usual explanation, "you just need to lose weight", is incomplete from the start.

How common it is, and why weight is not the whole story

The best measurement of insulin resistance is the euglycemic clamp, a research procedure in which insulin is infused and the glucose needed to keep blood sugar steady is counted. A meta-analysis pooled 28 such studies and found insulin sensitivity about 27 percent lower in women with PCOS than in weight-matched controls, a difference that held independent of BMI. A higher BMI made it worse still, by roughly another 15 percent (3).

So a lean woman with PCOS can be insulin resistant, and a heavier woman carries two sources of it, the condition and the weight. This is why the guideline repeats, in several places, that there are benefits to a healthy lifestyle even in the absence of weight loss, and asks doctors to be aware of weight stigma when they discuss it (1). Insulin resistance is something you have, not something you did.

Why it matters: glucose, heart, androgens

Across the higher-quality studies in a meta-regression, women with PCOS had 3.3 times the odds of impaired glucose tolerance and 2.9 times the odds of type 2 diabetes (4). The guideline states the risk is raised regardless of age and BMI, which is why it asks for glycemic status to be assessed at diagnosis in every woman and reassessed every one to three years (1). Cardiovascular risk is raised too, and the lipid profile and blood pressure belong in the same check (1).

The androgen link closes the loop. High insulin stimulates the ovaries to make more testosterone and tells the liver to make less SHBG, the protein that binds it, so more testosterone circulates free (2). That is the thread that connects a metabolic problem to irregular cycles and to the clinical signs of high androgens. Improve the insulin picture and the hormonal picture tends to follow, which is where lifestyle support earns its place at the top of the guideline (1).

Why your doctor does not measure it

You will read online that every woman with PCOS needs a fasting insulin or a HOMA-IR value. The guideline disagrees: "clinically available insulin assays are of limited clinical relevance and are not recommended in routine care" (1). Insulin values vary between laboratories and between days, and the ratios built on them are too noisy to steer decisions for one person.

Instead the guideline measures the consequence, glucose handling, and asks for the 75 g oral glucose tolerance test as the most accurate option regardless of BMI, with fasting glucose or HbA1c as fallbacks of lower accuracy (1). It asks for the OGTT again when a pregnancy is planned (1). And it treats insulin resistance as present in principle, which is why the management advice below applies to every woman with PCOS, whatever any insulin value says. The blood tests article lists the full set.

What moves it: muscle

Muscle is where most of the glucose from a meal goes, and a working muscle takes up glucose with less insulin than a resting one. The guideline's first management recommendation is lifestyle intervention, exercise alone or diet combined with exercise, for all women with PCOS, to improve metabolic health including central fat and lipids (1). It adds that no one type or intensity of exercise has been shown to beat another, so the right exercise is the one you keep doing (1).

The trials are consistent in direction. A meta-analysis of exercise interventions in PCOS found that vigorous exercise lowered HOMA-IR, a measure of insulin resistance, and improved other cardiometabolic markers (5). Another found that exercise training reduced fasting insulin, waist circumference and systolic blood pressure and improved lipids (6). The guideline's target is 150 to 300 minutes of moderate activity a week, or 75 to 150 vigorous, plus muscle-strengthening on two non-consecutive days (1). The training article turns that into a 20-minute session.

What moves it: the plate

Here the guideline is almost blunt: there is no evidence to support any one diet composition over another for metabolic, hormonal, reproductive or psychological outcomes, and any pattern consistent with population guidelines for healthy eating will help (1). It warns specifically against unduly restrictive diets (1). So low-carbohydrate is an option, not a rule, and cutting carbohydrates to zero is nowhere in the evidence.

What the evidence does support is the quality and company of carbohydrates. A meta-analysis of ten randomized trials with 403 women found that lower glycemic index eating lowered insulin resistance and waist size compared with control diets (7). In practice that means slower carbohydrates, whole grains, legumes, fruit, eaten together with protein, fiber and fat rather than alone. The plate method article builds that into meals without counting anything.

What moves it: sleep, and where medicine comes in

Sleep is the quiet variable. Across 18 studies and 16,152 participants, women with PCOS had about six times the odds of disturbed sleep (8), and the guideline notes a higher prevalence of obstructive sleep apnea independent of BMI (1). Short or broken sleep worsens insulin sensitivity in everyone; in PCOS it stacks on an existing deficit.

Medicine is your doctor's domain, but the guideline's positions are worth knowing. Metformin should be considered for adults with PCOS and a BMI of 25 or more for metabolic outcomes, may be considered below that, and has similar efficacy to active lifestyle intervention; monitoring B12 should be considered with long-term use (1). Inositol could be considered based on preference, with potential improvement in metabolic measures but limited clinical benefit, and no type or dose can be recommended (1); a meta-analysis of nine small trials found lower fasting insulin and HOMA-IR with myo-inositol (9). GLP-1 medications may be considered for weight management as in the general population (1). None of these is a reason to skip the plate and the training; the guideline pairs them.

A week that respects insulin, without a diet

Put together, the evidence describes a week rather than a regime. Two or three strength sessions, a daily walk, protein at breakfast, carbohydrates kept but paired, and a sleep window that is defended like an appointment. If a doctor adds metformin, the week stays the same, because the guideline says the two work alongside each other (1).

That week is what HERA's Training Plan and Meal Plan write out for your equipment, your kitchen and your days, with the Blood Test Guide making sure the glucose test is on your doctor's list first. The goal is a body that handles a meal and a day with less effort.

Only a doctor can diagnose PCOS or prescribe medication. This article is information from certified coaches, not medical advice, and it does not replace a consultation.

References

  1. Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023;108(10):2447-2469. doi.org/10.1210/clinem/dgad463
  2. Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981-1030. doi.org/10.1210/er.2011-1034
  3. Cassar S, Misso ML, Hopkins WG, Shaw CS, Teede HJ, Stepto NK. Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies. Hum Reprod. 2016;31(11):2619-2631. doi.org/10.1093/humrep/dew243
  4. Kakoly NS, Khomami MB, Joham AE, et al. Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression. Hum Reprod Update. 2018;24(4):455-467. doi.org/10.1093/humupd/dmy007
  5. Patten RK, Boyle RA, Moholdt T, et al. Exercise interventions in polycystic ovary syndrome: a systematic review and meta-analysis. Front Physiol. 2020;11:606. doi.org/10.3389/fphys.2020.00606
  6. Benham JL, Yamamoto JM, Friedenreich CM, Rabi DM, Sigal RJ. Role of exercise training in polycystic ovary syndrome: a systematic review and meta-analysis. Clin Obes. 2018;8(4):275-284. doi.org/10.1111/cob.12258
  7. Kazemi M, Hadi A, Pierson RA, Lujan ME, Zello GA, Chilibeck PD. Effects of dietary glycemic index and glycemic load on cardiometabolic and reproductive profiles in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Adv Nutr. 2021;12(1):161-178. doi.org/10.1093/advances/nmaa092
  8. Zhang J, Ye J, Tao X, Lu W, Chen X, Liu C. Sleep disturbances, sleep quality, and cardiovascular risk factors in women with polycystic ovary syndrome: systematic review and meta-analysis. Front Endocrinol. 2022;13:971604. doi.org/10.3389/fendo.2022.971604
  9. Unfer V, Facchinetti F, Orrù B, Giordani B, Nestler J. Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocr Connect. 2017;6(8):647-658. doi.org/10.1530/EC-17-0243
The PCOS Plan

When you want it written for you

Four documents from your intake: the blood tests to ask for, supplements checked against your medication, eight weeks of training, 60 days of meals. Written by certified coaches, read by a second coach, in your inbox within 48 hours. Alongside your medical care, never instead of it.